SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-085578
Filing Date
2023-11-13
Accepted
2023-11-13 08:28:23
Documents
16
Period of Report
2023-11-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea188201-6k_immuron.htm 6-K 12934
2 INVESTOR WEBINAR PRESENTATION ea188201ex99-1_immuron.htm EX-99.1 21343
3 GRAPHIC image_001.jpg GRAPHIC 1254
4 GRAPHIC ex99-1_001.jpg GRAPHIC 356749
5 GRAPHIC ex99-1_002.jpg GRAPHIC 898456
6 GRAPHIC ex99-1_003.jpg GRAPHIC 790593
7 GRAPHIC ex99-1_004.jpg GRAPHIC 904427
8 GRAPHIC ex99-1_005.jpg GRAPHIC 1147787
9 GRAPHIC ex99-1_006.jpg GRAPHIC 1090179
10 GRAPHIC ex99-1_007.jpg GRAPHIC 665271
11 GRAPHIC ex99-1_008.jpg GRAPHIC 1175761
12 GRAPHIC ex99-1_009.jpg GRAPHIC 964240
13 GRAPHIC ex99-1_010.jpg GRAPHIC 358074
14 GRAPHIC ex99-1_011.jpg GRAPHIC 1367360
15 GRAPHIC ex99-1_012.jpg GRAPHIC 17461
16 GRAPHIC ex99-1_013.jpg GRAPHIC 21041
  Complete submission text file 0001213900-23-085578.txt   13455562
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 231395382
SIC: 2834 Pharmaceutical Preparations